₹0.07
(Market cap
₹63 Cr
Revenue (TTM)
₹51 Cr
P/E Ratio
14
P/B Ratio
0.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹5 Cr
-
ROE
11.7 %
-
ROCE
12.6 %
-
Industry P/E
302.4
-
EV/EBITDA
5.4
-
Debt to Equity
0.8
-
Book Value
₹43.5
-
EPS
₹2.2
-
Face value
10
-
Shares outstanding
22,190,628
10 Years Aggregate
CFO
₹95.10 Cr
EBITDA
₹141.74 Cr
Net Profit
₹33.56 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vivo Bio Tech
| -10.0 | 13.6 | -0.1 | -18.7 | 3.5 | -15.1 | -- |
|
BSE Healthcare
| 7.1 | 11.7 | 10.9 | 10.9 | 26.2 | 14.1 | 11.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Vivo Bio Tech
| -15.4 | 9.0 | 11.8 | -57.0 | 23.3 | 89.3 | -60.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vivo Bio Tech
|
28.4 | 63.1 | 51.4 | 4.5 | 22.0 | 5.2 | 14 | 0.7 |
| 187.3 | 2,943.6 | 2,796.8 | 118.8 | 8.1 | 2.3 | 24.8 | 0.5 | |
| 23.6 | 7.2 | 0.5 | 0.0 | 8.3 | -1.1 | -- | 1.8 | |
| 530.0 | 12,759.3 | 3,510.5 | 401.1 | 14.0 | 13.9 | 31.8 | 4.1 | |
| 65.4 | 232.3 | 133.8 | -0.3 | -0.7 | -0.6 | -- | 2.3 | |
| 197.8 | 8,968.1 | 2,803.3 | 361.8 | 15.5 | 14 | 24.9 | 3.2 | |
| 1,115.6 | 23,679.9 | 2,169.9 | 332.9 | 20.9 | 15.4 | 71.1 | 10.0 | |
| 4,767.7 | 10,992.5 | 935.0 | 257.9 | 34.3 | 78.9 | 42.6 | 24.3 | |
| 33.1 | 486.6 | 0.0 | 1.6 | -- | -0.5 | 302.4 | 18.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Vivo Bio Tech
Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vitro, in vivo, toxicity studies, pharmacological investigations, pharmacokinetic... and toxico kinetic studies, genotoxicity screening, analytical services, etc. It also supplies SPF lab animals. The company was formerly known as Sunshine Factors & Exports Limited and changed its name to Vivo Bio Tech Limited in September 2002. Vivo Bio Tech Limited was incorporated in 1987 and is based in Hyderabad, India. Read more
-
Incorporated
1987
-
Chairman
--
-
Managing Director
--
-
Headquarters
Hyderabad, Telangana
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Vivo Bio Tech
What is the current share price of Vivo Bio Tech Ltd Today?
The share price of Vivo Bio Tech Ltd is ₹28.44 (BSE) as of 08-May-2026 IST. Vivo Bio Tech Ltd has given a return of 3.46% in the last 3 years.
What is the current PB & PE ratio of Vivo Bio Tech Ltd?
The P/E ratio of Vivo Bio Tech Ltd is 13.97 times as on 08-May-2026, a 95 discount to its peers’ median range of 302.40 times.
The P/B ratio of Vivo Bio Tech Ltd is 0.65 times as on 08-May-2026, a 64 discount to its peers’ median range of 1.83 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
8.01
|
0.83
|
|
2024
|
25.29
|
1.18
|
|
2023
|
10.86
|
0.56
|
|
2022
|
25.69
|
1.23
|
|
2021
|
11.31
|
1.57
|
What is the 52 Week High and Low of Vivo Bio Tech Ltd?
The 52-week high and low of Vivo Bio Tech Ltd are Rs 43.35 and Rs 20.35 as of 09-May-2026.
What is the market cap of Vivo Bio Tech Ltd?
Vivo Bio Tech Ltd has a market capitalisation of ₹ 63 Cr as on 08-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Vivo Bio Tech Ltd?
Before investing in Vivo Bio Tech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.